TY  - JOUR

T1  - Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial (vol 50, pg 1844, 2007)

JO  - J AM COLL CARDIOL

PY  - 2007/11/27

AU  - Cannon CP

AU  - Husted S

AU  - Harrington RA

AU  - Scirica BM

AU  - Emanuelsson H

AU  - Peters G

AU  - Storey RF

ED  - 

DO  - DOI: 10.1016/j.jacc.2007.11.001

VL  - 50

IS  - 22

SP  - 2196

EP  - 2196

Y2  - 2024/12/22

ER  -